Pharmaceutical giant Pfizer is reported to be close to selling its $1.9 billion annual turnover infant nutrition business to Nestle for between $9 billion and $10 billion. With roughly 80%
Tag "Pfizer"
Pfizer has invested $100m in the expansion of its Singapore Nutrition Plant, which manufactures nutritional products for infants and children. The expansion, which brings the total investment in the plant
The Magazine
Advertisements
